CRIS Current Research Information System

PADELLA, ANTONELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.835
AS - Asia 3.206
EU - Europa 3.107
AF - Africa 281
SA - Sud America 137
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 7
Totale 10.582
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.788
VN - Vietnam 1.003
GB - Regno Unito 856
CN - Cina 832
SG - Singapore 808
SE - Svezia 453
IT - Italia 425
DE - Germania 388
HK - Hong Kong 219
FR - Francia 158
IN - India 156
NL - Olanda 151
RU - Federazione Russa 148
IE - Irlanda 126
BR - Brasile 98
TG - Togo 81
FI - Finlandia 77
ZA - Sudafrica 67
EE - Estonia 62
CI - Costa d'Avorio 56
NG - Nigeria 55
BG - Bulgaria 52
UA - Ucraina 48
CH - Svizzera 44
BE - Belgio 40
KR - Corea 39
JO - Giordania 35
CA - Canada 30
AR - Argentina 22
ES - Italia 20
SC - Seychelles 18
ID - Indonesia 15
IR - Iran 15
JP - Giappone 15
MX - Messico 14
AT - Austria 13
GR - Grecia 13
BD - Bangladesh 12
PL - Polonia 10
UZ - Uzbekistan 9
EU - Europa 8
TR - Turchia 7
IQ - Iraq 6
CL - Cile 5
MK - Macedonia 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
EC - Ecuador 4
HR - Croazia 4
LT - Lituania 4
MY - Malesia 4
PK - Pakistan 4
PY - Paraguay 4
NZ - Nuova Zelanda 3
PE - Perù 3
TW - Taiwan 3
KG - Kirghizistan 2
KZ - Kazakistan 2
LV - Lettonia 2
MA - Marocco 2
PH - Filippine 2
PS - Palestinian Territory 2
PT - Portogallo 2
RO - Romania 2
SA - Arabia Saudita 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AZ - Azerbaigian 1
BH - Bahrain 1
BY - Bielorussia 1
CO - Colombia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GE - Georgia 1
GT - Guatemala 1
HU - Ungheria 1
IL - Israele 1
KE - Kenya 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
NI - Nicaragua 1
NP - Nepal 1
SK - Slovacchia (Repubblica Slovacca) 1
TM - Turkmenistan 1
Totale 10.582
Salva come PNG Salva come JPEG
Città #
Southend 789
Dong Ket 684
Singapore 536
Ashburn 483
Chandler 411
Fairfield 288
Ann Arbor 277
Hong Kong 219
Houston 190
Beijing 185
Wilmington 168
Seattle 149
Woodbridge 147
Princeton 126
Dublin 125
Santa Clara 116
Cambridge 115
Boardman 105
Bologna 90
Lomé 81
Hefei 79
New York 75
Nanjing 63
Westminster 62
Padova 60
Los Angeles 59
Medford 58
Abidjan 56
Munich 53
Sofia 52
Helsinki 44
Ho Chi Minh City 42
Abeokuta 40
Brussels 39
Bern 36
Seoul 35
Amman 34
Berlin 31
Hanoi 30
Bremen 29
Redwood City 29
Dallas 27
Saint Petersburg 27
Hebei 26
Turin 26
Buffalo 24
Redondo Beach 24
Changsha 23
Jinan 23
Shenyang 22
Milan 21
Nanchang 20
Jiaxing 19
Redmond 19
Florence 18
Guangzhou 18
Lappeenranta 17
Paris 17
Shanghai 17
Frankfurt am Main 16
Mountain View 16
Turku 16
Falkenstein 15
San Diego 15
Toronto 15
London 13
Tokyo 13
Norwalk 12
Falls Church 11
Hangzhou 11
Tianjin 11
Brooklyn 10
Chennai 10
Jakarta 10
Taizhou 10
Chengdu 9
Roubaix 9
São Paulo 9
Vienna 9
Zhengzhou 9
Chicago 8
Manchester 8
Ningbo 8
Rome 8
San Jose 8
Stockholm 8
Bengaluru 7
Düsseldorf 7
Haikou 7
Monmouth Junction 7
Orem 7
Phoenix 7
Salamanca 7
Athens 6
Fuzhou 6
Haiphong 6
Leawood 6
Montreal 6
Romainville 6
Xi'an 6
Totale 7.066
Salva come PNG Salva come JPEG
Nome #
Aneuploid acute myeloid leukemia exhibits a signature of genomic alterations in the cell cycle and protein degradation machinery 335
Adult "Triple Negative" ACUTE Lymphoblastic Leukemia Genome Wide Characterization 278
A Specific Pattern of Somatic Mutations Associates with Poor Prognosis Aneuploid Acute Myeloid Leukemia: Results from the European NGS-PTL Consortium 271
Aggressive Aneuploid Acute Myeloid Leukemia Is Dependent on Alterations of P53, Gain of APC and PLK1 and Loss of RAD50 260
Chromothripsis in acute myeloid leukemia: Biological features and impact on survival 241
Alterations in phosphatidylinositol 3-phosphate (PI3P) pathway and cAMP pathway confirm poor prognosis and reduced overall survival (OS) in a series of 209 acute myeloid leukemia patients 232
Blinatumomab Is Safe and Effective in Relapsed and MRD Positive B-ALL CD19+ Patients: The Bologna Compassionate Program Experience 221
Alterations in Pathways Regulating Phosphatidil Inositol 3 Phosphate (PI3P) Produce Both Cell Proliferation and Therapy Resistance, and Define a Group of Patients with Poor Prognosis in Acute Myeloid Leukemia (AML) 218
The alteration in key regulator genes of autophagy is mainstream mechanism of therapy resistance and impact prognosis of acute myelogenous leukemia (AML): results from diagnosis genomic analysis on 148 consecutive patients treated with intensive chemotherapy and long-term survival follow-up 215
Alterations of BRCA1 and PALB2 Define a Novel Class of Complex-Karyotype AML with a Very Bad Prognosis 213
Co-occurrence of alterations in the DNA damage repair genes synergize with uncontrolled proliferation and associate with very-poor prognosis in acute myeloid leukemia patients 210
Chromothripsis in Acute Myeloid Leukemia Is Strongly Associated with Poor Prognosis and TP53 Alterations 206
Chromothripsis in AML patients: A new mechanism of cancer initiation and progression 201
A cell cycle-related genomic and transcriptomic signature distinguish aneuploid and euploid acute myeloid leukemia 201
Optimized pipeline of MuTect and GATK tools to improve the detection of somatic single nucleotide polymorphisms in whole-exome sequencing data 196
SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis 183
Clustering Adult ACUTE Lymphoblastic Leukemia (ALL) Philadelphia Negative (Ph-) By Whole Exome Sequencing (WES) Analysis 182
Fanconi anemia gene variants in therapy-related myeloid neoplasms 181
Ex-Vivo Drug Response Profiling for Precision Medicine Approaches in Acute Myeloid Leukemia with the Open Microwell Microfluidic Platform 171
Copy number variants signature in two patients with relapsed acute promyelocytic leukemia 169
Distinct pattern of alterations in tp53 mutated and wild type acute myeloid leukemia (AML) patients 169
Deficient necroptosis pathway as a negative prognostic factor in acute myeloid leukemia. 169
Novel Genomic Patterns of Metabolic Remodeling in Acute Myeloid Leukemia 164
Impact on survival of catastrophic karyotype events in 101 consecutive acute myeloid leukemia (AML) patients: High risk karyotype and chromothripsis 162
Loss of PALB2 predicts poor prognosis in acute myeloid leukemia and suggests novel therapeutic strategies targeting the DNA repair pathway 161
A new biomarker of response to 5-azacitidine therapy in MDS and AML patients: SIRPB1 159
An analysis pipeline for variant discovery in Whole Exome Sequencing data of cancer samples. 158
Clec12a: A new AML stem cell-associated antigen 158
SIRPB1 Is a Strong Predictor Biomarker of Response to 5-Azacitidine Therapy in MDS and AML Patients 158
Survival analysis of patients carrying different FLT3 mutations (internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations) in 459 consecutive non M3 newly diagnosed acute myeloid leukemia (AML) 154
MHC-I Antigen Presentation Role in Immune Escape of Acute Myeloid Leukemia with High Burden of Genomic Aberration 154
Very Poor Outcome and Chemoresistance of Acute Myeloid Leukemia Patients with TP53 Mutations: Correlation with Complex Karyotype and Clinical Outcome 153
Gemtuzumab-Ozogamicin Containing Regimens As Induction Therapy Give the Highest Complete Remission Rate and the Longest Overall Survival Compared with Other Induction Regimens in Patients with Newly Diagnosed Acute Myeloid Leukemia 153
Dissecting the Molecular Mechanisms of Aneuploidy in Acute Myeloid Leukemia By Next Generation Sequencing 152
Microarray analysis to identifiy novel copy number alterations in acute myeloid leukemia 151
You have accessEx-Vivo Drug Response Profiling for Precision Medicine Approaches in Acute Myeloid Leukemia with the Open Microwell Microfluidic Platform 150
Two or More Chemotherapy Consolidation Courses, Followed By Autologous Bone Marrow Transplantation, and MRD Negativity, Give Long Term Overall Survival in Acute Myeloid Leukemia Patients 149
RNA Sequencing Reveals Novel and Rare Fusion Transcripts in Acute Myeloid Leukemia 145
Prognostic significance of alterations of pathways regulating autophagy in acute myeloid leukemia 145
A New Entity of Acute Myeloid Leukemia Driven By Epigenetic and Somatic Dis-Regulation of Uncx, a Novel Homeobox Transcription Factor Gene 145
Genome-Wide Molecular Portrait of Aggressive Systemic Mastocytosis and Mast Cell Leukemia Depicted By Whole Exome Sequencing and Copy Number Variation Analysis 136
TP53 mutations are mutually exclusive with FLT3 and NPM mutations in AML patients and are strongly associated with complex karyotype and poor outcome 135
Genomic-Wide Analysis By High Resolution SNP Array Identifies Novel Genomic Alteration in Acute Myeloid Leukemia 133
SNP array reveals a new deletion of JAK2 in AML patients 133
Exploring the role of PARP1 inhibition in enhancing antibody–drug conjugate therapy for acute leukemias: insights from DNA damage response pathway interactions 132
Separase overexpression defines a new subset of acute myeloma leukemia patients characterized by high CD34 and MYC levels 132
You have accessA New Entity of Acute Myeloid Leukemia Driven By Epigenetic and Somatic Dis-Regulation of Uncx, a Novel Homeobox Transcription Factor Gene 132
Override the doxorubicin-induced G2/M checkpoint using cell-cycle checkpoint inhibitors on acute lymphoblastic leukemia 131
Genomic wide microarray analysis identifies novel copy number alterations in adult acute myeloid leukemia 131
Tp53 mutation screening in adult acute myeloid leukemia (AML) patients shows a strong association with complex karyotype and poor outcome 130
You have accessAlterations in Pathways Regulating Phosphatidil Inositol 3 Phosphate (PI3P) Produce Both Cell Proliferation and Therapy Resistance, and Define a Group of Patients with Poor Prognosis in Acute Myeloid Leukemia (AML) 127
Survival analysis of 409 consecutive patients with newly diagnosed acute myeloid leukemia treated with intensive induction therapy, with or without the addition of gemtuzomab-ozagomicin (GO) 127
Very poor outcome and chemoresistance of acute myeloid leukemia patients with TP53 mutations: Correlation with complex karyotype and clinical outcome 127
A Three-Genes Signature of Anti-Apoptotic Genes Showed Different Mechanisms in Preventing Apoptosis in Acute Myeloid Leukemia Cells and Could Provide an Useful Model to Establish the Proper BH3-Mimetich Drug or Combination 125
Novel fusion transcripts identified by RNAseq cooperate with somatic mutations in the pathogenesis of acute myeloid leukemia 122
Leukemia Associated TP53 Mutations in AML Patients ARE Strongly Associated with Complex Karyotype and Poor Outcome 121
Specific chromosomic alterations confer therapy resistance in a cohort of 49 patients with newly diagnosed acute myeloid leukemia treated with intensive chemotherapy 121
You have accessMine the Stability of the G2/M Checkpoint to Break Down Acute Lymphoblastic Leukemia Defenses Against Antineoplastic Drugs 119
Ultra-Deep Sequencing Strategy Is a Precious Tool to Find Small Clones Harbouring FLT3 Mutations in AML Patients 114
Gene expression signature of aneuploidy in acute myeloid leukemia 112
Pharmacological interaction and side effects in oncohaematology: a retrospective observational study 108
Next-Generation Sequencing Analysis Revealed That BCL11B Chromosomal Translocation Cooperates with Point Mutations in the Pathogenesis of Acute Myeloid Leukemia 107
New JAK2 heterozygous loss: A role in overall survival in acute myeloid leukemia patients 107
Aneuploidy: Cancer strength or vulnerability? 105
Therapeutic Targeting of Acute Myeloid Leukemia by Gemtuzumab Ozogamicin 100
Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies 98
Signatures of disease outcome severity in the intestinal fungal and bacterial microbiome of COVID-19 patients 95
Pharmacological Inhibition of WIP1 Sensitizes Acute Myeloid Leukemia Cells to the MDM2 Inhibitor Nutlin-3a 61
Totale 10.814
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.909
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.909
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.322 0 0 0 0 0 76 48 96 105 51 81 865
2021/20221.468 171 44 79 142 154 80 41 80 79 87 275 236
2022/20231.682 189 240 98 227 120 131 54 72 286 46 138 81
2023/2024464 16 62 22 49 31 138 28 39 25 29 10 15
2024/20251.654 37 256 150 114 158 30 203 77 13 210 71 335
2025/20261.723 398 243 272 237 427 146 0 0 0 0 0 0
Totale 10.814